Uscom Limited (ASX:UCM)


right-arrow Created with Sketch. 0 (0%)
MCAP $18.86M
Last trade 15.55pm 28/01/2022 20mins delayed

Latest Announcements

24/01/2022 Price SensitivePSUCMUscom Limited
20/12/2021UCMUscom Limited
17/12/2021UCMUscom Limited
16/12/2021UCMUscom Limited
16/12/2021UCMUscom Limited
16/12/2021UCMUscom Limited
16/12/2021UCMUscom Limited
15/12/2021UCMUscom Limited

Company Overview

USCOM Limited is engaged in the development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company manages a network of distribution partners across the world for the sale of its equipment to hospitals and other medical care locations. Its geographic segments include Singapore, Australia, China, South East Asia, Europe and the United States. The Company has approximately three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring, including the USCOM 1A, which is an hemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment, USCOM BP+, which is a supra systolic oscillometric Central Blood Pressure monitor that measures blood pressure and blood pressure waveforms only previously available using cardiac catheterization, and the Uscom SpiroSonic spirometers, which is a digital pulmonary testing device.

UCM in the news

Uscom (UCM) has been granted Russian regulatory and distribution approval for its…
Uscom (UCM) has received key European CE mark approval for its Uscom…
Uscom (UCM) has created two specialised cardiovascular monitors for sale in ChinaThe…
Uscom’s (UCM) BP+ product has received approval for sale in China, from…

Search Previous Announcements